# Ra Pharmaceuticals, Inc.

Ra Pharmaceuticals, Inc. is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** Ra Pharmaceuticals, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001481512

## About

Ra Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001481512, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-02-27, it reported annual revenue of USD 3,000,000; net income of USD -102,688,000; total assets of USD 284,152,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $3.0M (USD 3,000,000)
- **Net income:** -$102.7M (USD -102,688,000)
- **Total assets:** $284.2M (USD 284,152,000)
- **Cash and equivalents:** $265.0M (USD 264,992,000)
- **Operating cash flow:** -$87.4M (USD -87,361,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $2.5M (USD 2,500,000)
- **Net income:** -$64.9M (USD -64,943,000)
- **Total assets:** $219.2M (USD 219,220,000)
- **Cash and equivalents:** $209.8M (USD 209,822,000)
- **Operating cash flow:** -$54.9M (USD -54,946,000)

### FY2017 (period ended 2017-12-31)

- **Net income:** -$54.4M (USD -54,439,000)
- **Total assets:** $80.2M (USD 80,197,000)
- **Cash and equivalents:** $70.4M (USD 70,381,000)
- **Operating cash flow:** -$46.8M (USD -46,779,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $4.9M (USD 4,928,000)
- **Net income:** -$28.9M (USD -28,864,000)
- **Total assets:** $126.8M (USD 126,818,000)
- **Cash and equivalents:** $117.8M (USD 117,812,000)

## Recent SEC filings

- Form 10-K/A — filed 2020-04-03 — period 2019-12-31 — 10-K/A
- Form 8-K — filed 2020-04-02 — period 2020-04-02 — FORM 8-K
- Form 8-K — filed 2020-03-31 — period 2020-03-30 — FORM 8-K
- Form 8-K — filed 2020-03-16 — period 2020-03-11 — FORM 8-K
- Form 8-K — filed 2020-02-28 — period 2020-02-28 — FORM 8-K
- Form 10-K — filed 2020-02-27 — period 2019-12-31 — 10-K
- Form 8-K — filed 2019-12-18 — period 2019-12-17 — FORM 8-K
- Form 8-K — filed 2019-11-25 — period 2019-11-22 — FORM 8-K
- Form 10-Q — filed 2019-11-07 — period 2019-09-30 — 10-Q
- Form 8-K — filed 2019-10-10 — period 2019-10-09 — 8-K
- Form 10-Q — filed 2019-08-07 — period 2019-06-30 — 10-Q
- Form 8-K — filed 2019-07-26 — period 2019-07-23 — 8-K

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/ra-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology